← All indications
Encephalitis
Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.
Subtype terms (5)
More specific conditions that are subtypes of Encephalitis in the MeSH hierarchy.
- Anti-N-Methyl-D-Aspartate Receptor Encephalitis
7 drugs (5 approved, 2 experimental)
- Cerebral Ventriculitis
6 drugs (4 approved, 2 experimental)
- Infectious Encephalitis
1 drug experimental
- Limbic Encephalitis
1 drug approved
- Meningoencephalitis
3 drugs approved
Drugs by status
Phase 4 trials (6)
Phase 3 trials (7)
Phase 2 trials (13)
Phase 1 trials (5)
Other trials (4)
Organizations
Organization Involved with Phase 4 Indications (32)
- Chiron
- Valneva
- Pfizer
- Sanofi
- Sanofi-Aventis
- Novartis
- Baxalta
- Changchun Keygen Biological Products Co., Ltd.
- INC Research
- Centers for Disease Control and Prevention, China
- National Institute of Mental Health and Neuro Sciences, India
- University of London
- Indian Institute of Science
- Seoul National University
- Siriraj Hospital
- University of Liverpool
- Assiut University
- University of Vienna
- International Center for Diarrheal Disease Research
- Boryung Pharmaceutical Company
- Medical University of Vienna
- Orebro University
- Government of China
- Chiangmai University
- Rajavithi Hospital, Bangkok
- Wellcome Trust
- Szpital Jana Pawla II Oddzial Neuoinfekcji
- KhonKaen University
- Centers for Disease Control and Prevention (CDC)
- PATH
- +2 more
Organization Involved with Phase 3 Indications (49)
- CSL Behring
- Astellas
- Octapharma
- National Institute of Allergy and Infectious Diseases (NIAID)
- Swedish Institute for Infectious Disease Control
- Gachon University
- Inje University
- Korea Cancer Center Hospital
- Kyung Hee University
- Mahidol University
- Norwegian University of Science and Technology
- Osaka University
- University Hospital of North Norway
- University of Bergen
- University of Bonn
- Sormland County Council, Sweden
- University of Utah
- Vince & Associates
- Karolinska Institute
- University of Oxford
- Royal Liverpool & Broadgreen University Hospitals NHS Truts
- Wonju Christian Hospital
- Catholic University of Korea
- Wojewodzki Szpital
- Ewha Womans University
- Inha University
- Samodzielny Publiczny Szpital
- Sri Lanka Ministry of Healthcare and Nutrition
- Telemark Hospital Trust
- Heart of America Research Institute
- +19 more
Organization Involved with Phase 2 Indications (31)
- Green Cross Corporation
- Genentech
- MacroGenics
- National Institutes of Health (NIH)
- National Cancer Institute (NCI)
- National Institute on Aging (NIA)
- United States Army
- Azad University
- Duke University
- Emory University
- University of Washington
- Indian Council of Medical Research
- King George's Medical University
- Singapore General Hospital
- Vinmec International Hospital
- B.P. Koirala Institute of Health Sciences
- University of Cambridge
- University of Toulouse
- Pharmaceutical Research Associates, Inc. (PRA)
- Friedrich Schiller University
- University of Texas at Houston
- KH Elisabethinen Linz
- Government Medical College, Baroda, India
- Dr Atul's Child Hospital, Jaipur
- Fondation Plan Alzheimer
- Austrian Science Fund (FWF)
- Kanti Children's Hospital
- ASOKLIF
- Assistance Publique - Hôpitaux de Paris
- The Cleveland Clinic
- +1 more
Organization Involved with Phase 1 Indications (15)
- Sarepta Therapeutics
- Bavarian Nordic
- Ichor Medical Systems Incorporated
- SRI International
- The EMMES Corporation
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Johns Hopkins University
- University of California, San Francisco
- Vanderbilt University
- Department of Defense
- Battelle
- Johnson County Clin-Trials
- DynPort Vaccine Company LLC
- NW Kinetics
- Leidos
Organization Involved with Other Experimental Indications (7)